Create Account | Sign In: Author or Forum

News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
Category: Gynecology | Infections | AIDS | Reproductive Medicine | Research | Immunology | News

Back to Health News

‘Superinfected’ Patients Give Clues to Fighting HIV

Last Updated: March 29, 2012.

Women infected more than once from different partners can have stronger immune response.


Women infected more than once from different partners can have stronger immune response

Share |

Comments: (0)




THURSDAY, March 29 (HealthDay News) -- A stronger immune response occurs in women who have been infected with two different strains of HIV by two different sexual partners than in women infected with one strain of HIV, a new study finds.

This type of dual infection is called HIV "superinfection."

The finding that a mixture of different HIV strains may be one way to trigger a more powerful immune system antibody response may prove useful in efforts to develop an HIV vaccine in the fight against AIDS, according to the researchers at the Fred Hutchinson Cancer Research Center in Seattle.

The researchers tracked the immune activity of 12 superinfected women in Kenya for five years. Compared to singly infected women, the superinfected women had about 70 percent more neutralizing antibodies (agents the immune system uses to fight invaders) and their antibodies' ability to neutralize HIV was almost 50 percent stronger.

The study appears online March 29 in the journal PLoS Pathogens.

"We found that women who had been infected twice not only had more potent antibody responses, but some of these women had 'elite' antibody activity, meaning that they had a broad and potent ability to neutralize a wide variety of strains of HIV over a sustained period of time," senior author Julie Overbaugh said in a research center news release.

Only about 1 percent of HIV-infected people are "elite neutralizers," the authors noted.

"Individuals who become superinfected with a second virus from a different partner represent a unique opportunity for studying the antibody response and may provide insights into the process of developing broad neutralizing antibodies that could inform HIV-vaccine design," Overbaugh said.

It is estimated that more than 1.1 million Americans have HIV and someone becomes newly infected about every 10 minutes, according to the U.S. Department of Health and Human Services.

Many experts consider an HIV vaccine to be the best way to offer long-term protection against HIV but efforts to develop such a vaccine have achieved only limited success.

More information

The New Mexico AIDS Education and Training Center has more about HIV/AIDS vaccination.

SOURCE: Fred Hutchinson Cancer Research Center, news release, March 29, 2012

Copyright © 2012 HealthDay. All rights reserved.

Previous: People Stir Up Millions of Bacteria When Entering a Room: Study Next: Health Tip: Caring for a Chemical Burn

Reader comments on this article are listed below. Review our comments policy.

Submit your opinion:





Remember my personal information

Notify me of follow-up comments?


Useful Sites
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2016
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.